A Phase IV, Randomized, Open-Label, Active Controlled Study to Compare the Effects of Tarka [trandolapril/verapamil] and Hyzaar [losartan/hydrochlorothiazide] on Glucose Tolerance in Subjects With Metabolic Syndrome

Trial Profile

A Phase IV, Randomized, Open-Label, Active Controlled Study to Compare the Effects of Tarka [trandolapril/verapamil] and Hyzaar [losartan/hydrochlorothiazide] on Glucose Tolerance in Subjects With Metabolic Syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Mar 2009

At a glance

  • Drugs Losartan/hydrochlorothiazide; Verapamil/trandolapril
  • Indications Diabetes mellitus; Metabolic syndrome
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms STAR
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 16 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top